NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/27/2022
Back to search
Official data from USPTO
TRANSCENTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
04/21/2023
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
03/12/2021
Registration date
09/27/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2022
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
5
Owner type
99
Owner location
SUZHOU, CN
Examiner
LAPTER, ALAIN J
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized word TRANSCENTA.
Holders and representatives
Holders
SUZHOU TRANSCENTA THERAPEUTICS CO., LTD.
Mabspace Biosciences (Suzhou) Co., Limited
Representatives
Paulo A. de Almeida Patel & Almeida, P. C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biochemical medicines for the treatment of cancermusculoskeletalgenitourinaryoncologicalophthalmicgastrointestinalimmune system related diseases and disorders; Dietary supplements in the form of liquid; Pharmaceutical preparations for the treatment of cancermusculoskeletalgenitourinaryoncologicalophthalmicgastrointestinalimmune system related diseases and disorders; Biological preparations for medical purposes for the treatment of cancermusculoskeletalgenitourinaryoncologicalophthalmicgastrointestinalimmune system related diseases and disorders; Drugs for medical purposes for the treatment of cancermusculoskeletalgenitourinaryoncologicalophthalmicgastrointestinalimmune system related diseases and disorders; Injectable pharmaceuticals for the treatment of cancermusculoskeletalgenitourinaryoncologicalophthalmicgastrointestinalimmune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of cancermusculoskeletalgenitourinaryoncologicalophthalmicgastrointestinalimmune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2022
PUBO
PUBLISHED FOR OPPOSITION
07/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2022
ADBS
1(B) BASIS DELETED; NEW BASIS REQUESTED
06/07/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
06/06/2022
APET
ASSIGNED TO PETITION STAFF
06/01/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/12/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
05/12/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/04/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/16/2021
PUBO
PUBLISHED FOR OPPOSITION
11/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/27/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/11/2021
DOCK
ASSIGNED TO EXAMINER
10/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/14/2021
NWAP
NEW APPLICATION ENTERED
03/16/2021
Continuous trademark protection
Get notified about every new filing that threatens TRANSCENTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.